Financials
- Financial year
- 2025
- Total assets
- €48,660
- Profit
- €22,569
- Solvency
- 50.5%
far.mar.sie.
ActiveSummary
far.mar.sie. has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €24,569 and a net result of €22,569. Its solvency ranks better than 65% of 22,554 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€48,660total assets 2025
- Equity
- €24,569
- Profit
- €22,569
Turnover not published (micro format)
Why 88raises riskFounded in 2025Size: total assets €48,660lowers riskLiquidity: current ratio 2.22, cash €37,504Equity €24,569 (50.5% of total assets)Show the evidence
Checked score
Score 2025
88
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 81% of its sector peers (NACE 47, micro)
Financial strength
Strong
Solvency
75
equity 50.5% of total assets
Liquidity
78
short-term debt 45.1% · cash 77.1%
Profitability
100
return on assets 46.4%
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
07-2026: 1.8%
08-2026: 1.9%▲ +0.1 percentage points vs 07-2026highest value
09-2026: 0.4%▼ -1.5 percentage points vs 08-2026lowest value
10-2026: 0.4%● unchanged vs 09-2026
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.22, above the usual 1.5; short-term debt: 45.1% and cash: 77.1% of total assets), and 49.5% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 65% on solvency, 83% on liquidity and 96% on profitability.
The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 30 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filingDeviation from the deadline
2025
30 days late
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: MARTENS Sien (director) ·…
Key points
By topic
Board & ownership
- Board
- 1 member
- MARTENS SienDirector
Timeline
- Events
- 2
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 16-06-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 38
- Who signs
- Each director alone
- Purpose
- “De exploitatie, huur en verhuur van één of meer apotheken; Het verzorgen van vervangingen…” (deed in Dutch)
- Statutory auditor
- No statutory auditor
Key facts about far.mar.sie.
- What is the company number of far.mar.sie.?
- 1024.339.103. In Belgium the VAT number is the company number with BE in front: BE 1024.339.103.
- Where is far.mar.sie. based?
- The registered office is at Sint-Maartenplein 80, 3512 Hasselt.Company details
- What does far.mar.sie. do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of far.mar.sie.?
- Private limited company (BV).
- When was far.mar.sie. founded?
- On 16-06-2025.
- Is far.mar.sie. still active?
- Yes, far.mar.sie. is an active enterprise in the KBO register.
- What is the turnover of far.mar.sie.?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is far.mar.sie. profitable?
- In financial year 2025, far.mar.sie. made a profit of €22,569.
- Where can I find the annual accounts of far.mar.sie.?
- far.mar.sie. filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Companies related to far.mar.sie.
Comparable companies
- APOTHEEK HUMBLETZoutleeuw
- SMEETS TOMLint
- Apotheek Yves TarnaudAntwerpen
- PHARMACIE ZENROCMons
- APOTHEEK PEETERMANSHasselt
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.